The use of oral contraceptive pills to treat polycystic ovary syndrome
Year: 2025
Type: article
Abstract: The article examines the use of oral contraceptive pills (OCPs) as a treatment for Polycystic Ovary Syndrome (PCOS), a prevalent endocrine disorder among reproductive-age women characterized by irregular menstrual cycles, hyperandrogenism, and polycystic ovaries. OCPs are recommended as a first-line treatment for managing symptoms such as menstrual irregularities, hirsutism, and acne due to their ability to regulate hormonal imbalances by reducing circulating androgen levels and suppressing ovarian androgen production. Several studies suggest that OCPs may also offer metabolic benefits to PCOS patients by potentially improving insulin sensitivity and lowering the risk of type 2 diabetes, which is significant given the elevated cardiovascular and metabolic risks associated with PCOS. However, findings on the metabolic effects of OCPs in PCOS patients remain inconclusive, as results vary depending on factors such as OCP formulation, dosage, and patient characteristics like age and BMI. PCOS pathophysiology involves a complex interplay of hormonal and metabolic dysfunctions, with hyperandrogenism being a defining feature that contributes to the clinical symptoms. By regulating menstrual cycles and reducing androgen excess, OCPs play a pivotal role in managing these hormonal imbalances. However, individualized treatment is necessary, as patient-specific factors such as weight and prior health conditions can influence treatment outcomes and potential adverse effects, such as insulin resistance. Diagnostic criteria for PCOS are based on the Rotterdam consensus, which requires two of the following: oligo- or anovulation, hyperandrogenism, and polycystic ovaries observed via ultrasound. Variability in clinical presentation among patients underscores the need for a comprehensive assessment involving clinical, biochemical, and imaging evaluations. In conclusion, while OCPs are effective for managing the primary hormonal and reproductive symptoms of PCOS, a tailored approach is crucial for optimizing metabolic outcomes and addressing the diverse needs of PCOS patients. Further research is recommended to elucidate the complex relationship between OCP use, hormonal regulation, and metabolic implications in PCOS management.
Source: Multidisciplinary Reviews
Authors: Anshuli, Anjankar, Ashish
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7220335830
